Drugs for the Heart, 8th Edition (Original PDF from Publisher)

Unveiling the Therapeutic Arsenal for Cardiovascular Disease

Drug Classes for Cardiovascular Therapeutics

Drugs for the Heart, meticulously crafted by Drs. Lionel H. Opie and Bernard J. Gersh, offers a comprehensive guide to the pharmacological armamentarium employed in the management of cardiovascular disease. This indispensable reference empowers clinicians with a profound understanding of each drug class, enabling them to make informed decisions for optimal patient care.

Tailored Treatment for Every Cardiac Condition

The user-friendly “Which Drug for Which Disease” chapter serves as a quick reference, guiding practitioners in selecting the most appropriate drug for every cardiac condition. With a focus on real-world clinical experience, the editors provide evidence-based insights that translate directly into effective patient management.

Distilling Clinical Expertise

The editors, renowned experts in cardiovascular therapeutics, seamlessly blend clinical experience with cutting-edge research. This integration ensures that the information presented is both scientifically sound and highly relevant to clinical practice. The end-of-chapter summaries succinctly encapsulate the key points, facilitating rapid and efficient drug class review.

Pocket-Sized Convenience

The highly portable, pocket-sized format of Drugs for the Heart allows practitioners to access critical information at their fingertips. Unburdened by excessive bulk, this reference is an indispensable companion in the clinic, on rounds, and even on the go.

Embracing the Latest Pharmacologic Advances

Incorporating the latest drugs and drug classes, this comprehensive resource provides a window into the evolving pharmacologic landscape of cardiovascular medicine. The coverage of cutting-edge clinical trial results and evidence provides a solid foundation for evidence-based prescribing.

Managing the Multifaceted Challenges of Heart Disease

Drugs for the Heart recognizes the complexities of comorbid diseases, offering invaluable guidance for managing cardiovascular conditions in the context of other medical issues. The expertise of international contributors broadens the perspective, providing insights into global trends in cardiac drug therapy.

Visualizing Pharmacologic Mechanisms

Complementing the detailed text, dynamic full-color drawings vividly illustrate the pharmacologic and physiologic actions of various drug classes. This visual aspect enhances comprehension and aids in the retention of key information.

Online Access for Continuous Knowledge

Online access to the complete contents of Drugs for the Heart on Expert Consult ensures up-to-date information at all times. Regular updates led by renowned cardiologist Dr. Opie keep practitioners abreast of the latest advancements in the field. Purchasers gain online access until the next edition’s publication or until the current edition is no longer available for sale, whichever occurs first. In the event of a new edition being published within a year of purchase, access to the online platform is extended for an additional year from the original purchase date.

Elsevier remains committed to delivering essential medical knowledge to clinicians. In the unlikely event that access to the website is discontinued, a suitable replacement product, such as a downloadable or CD-ROM-based electronic version, will be offered to ensure uninterrupted access to this invaluable resource.